MyMD Pharmaceuticals® Investment Company Oravax Medical and Genomma Lab[...]
MyMD Pharmaceuticals® Announces Positive Clinical Data in Advance of[...]
MyMD Pharmaceuticals® Enrolls First Patient in Phase 2 Clinical Trial[...]
01/24/2022 | Press release | Distributed by Public on 01/24/2022 20:20
Please select the service you want to use:
Smartlinks | Ares Management Corporation | News | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Public Companies | Investment Companies | New York Stock Exchange (NYSE) | Börse Frankfurt | Börse Berlin | NYSE American | NYSE ARCA Equities | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact